Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Yamakawa, Kazuma ^a,b   Tasaki, Osamu ^b   Fukuyama, Miyuki ^a   Kitayama, Junichi ^a   Matsuda, Hiroki ^a   Nakamori, Yasushi ^a   Fujimi, Satoshi ^a   Ogura, Hiroshi ^b   Kuwagata, Yasuyuki ^b   Hamasaki, Toshimitsu ^b   Shimazu, Takeshi ^b  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; STEROID;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; JAPAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TERTIARY HEALTH CARE; WOUND INFECTION; CROSS INFECTION; DIAGNOSTIC TEST; EVALUATION; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MICROBIOLOGY; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION;

COHORT STUDIES; CROSS INFECTION; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; INTENSIVE CARE UNITS; JAPAN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT ADMISSION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 80055063829     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-303     Document Type: Article

References (20)

1. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010, 15(41):19688.
2. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006, 42(Suppl 2):S82-S89.
3. Ibelings MM, Bruining HA. Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 1998, 164(6):411-418.
4. Spencer RC. Epidemiology of infection in ICUs. Intensive Care Med 1994, 20(Suppl 4):S2-6.
5. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36(5):309-332. 10.1016/j.ajic.2008.03.002, 18538699.
6. Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 1998, 19(8):552-559. 10.1086/647872, 9758054.
7. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008, 61(1):26-38.
8. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002, 49(6):999-1005. 10.1093/jac/dkf009, 12039892.
9. Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003, 24(5):322-326. 10.1086/502215, 12785404.
10. Cook N. Methicillin-resistant Staphylococcus aureus versus the burn patient. Burns 1998, 24(2):91-98. 10.1016/S0305-4179(97)00114-9, 9625231.
11. Onorato M, Borucki MJ, Baillargeon G, Paar DP, Freeman DH, Cole CP, Mayhall CG. Risk factors for colonization or infection due to methicillin-resistant Staphylococcus aureus in HIV-positive patients: a retrospective case-control study. Infect Control Hosp Epidemiol 1999, 20(1):26-30. 10.1086/501556, 9927262.
12. O'Sullivan NP, Keane CT. Risk factors for colonization with methicillin-resistant Staphylococcus aureus among nursing home residents. J Hosp Infect 2000, 45(3):206-210. 10.1053/jhin.2000.0759, 10896799.
13. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011, 14(2):381-386. 10.1016/j.jval.2010.09.008, 21402305.
14. Song X, Perencevich E, Campos J, Short BL, Singh N. Clinical and economic impact of methicillin-resistant Staphylococcus aureus colonization or infection on neonates in intensive care units. Infect Control Hosp Epidemiol 2010, 31(2):177-182. 10.1086/649797, 20001732.
15. Sáez-Castillo AJ, Olmo-Jiménez MJ, Pérez Sánchez JM, Negrín Hernández MA, Arcos-Navarro A, Díaz-Oller J. Bayesian analysis of nosocomial infection risk and length of stay in a department of general and digestive surgery. Value Health 2010, 13(4):431-439. 10.1111/j.1524-4733.2009.00680.x, 20070640.
16. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman CA, Yu VL. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993, 94(3):313-328. 10.1016/0002-9343(93)90063-U, 8452155.
17. Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database Syst Rev 2006, (1):CD004884.
18. Gosselin RA, Roberts I, Gillespie WJ. Antibiotics for preventing infection in open limb fractures. Cochrane Database Syst Rev 2004, (1):CD003764.
19. Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ 2010, 340:c241. 10.1136/bmj.c241, 2822136, 20156911.
20. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, Marshall LF, Perot PL, Piepmeier J, Sonntag VKH, Wagner FC, Wilberger JE, Winn R. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990, 322(20):1405-1411. 10.1056/NEJM199005173222001, 2278545.